REFERENCES
- Amemiya T., Mizuno S., Yuasa H., Watanabe J. Development of emulsion type new vehicle for soft gelatin capsule. I. Selection of surfactants for development of new vehicle and its physicochemical properties. Chemical & Pharmaceutical Bulletin 1998; 46: 309–313
- Cadé D., Madit N. Liquid filling in hard gelatin capsules – preliminary steps. Bulletin Technologi Gattefossé 1996; 89: 15–21
- Charman S. A., Charman W. N., Rogge M. C., Wilson T. D., Dutko F. J., Pouton C. W. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharmaceutical Research 1992; 9: 87–93
- Christensen J. O., Schultz K., Mollgaard B., Kristensen H. G., Müllertz A. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. European Journal of Pharmaceutical Sciences 2004; 23: 287–296
- Constantinides P. P. Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharmaceutical Research 1995; 12: 1561–1572
- Gao P., Witt M. J., Haskell R. J., Zamora K. M., Shifflett J. R. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharmaceutical Development and Technology 2004; 9: 301–309
- Gao Z.-G., Choi G.-G., Shin H.-J., Park K.-M., Lim S.-J., Hwang K.-J., Kim C.-K. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. International Journal of Pharmaceutics 1998; 161: 75–86
- Gursoy R. N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy 2004; 58: 173–182
- Harrington E. C. The desirability function. Industrial Quality Control 1965; 21: 494–498
- Kawakami K., Yoshikawa T., Moroto Y., Kanaoka E., Takahashi K., Nishihara Y., Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I: Prediction design. Journal of Controlled Release 2002a; 81: 65–74
- Kawakami K., Yoshikawa T., Hayashi T., Nishihara Y., Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. II: In vivo study. Journal of Controlled Release 2002b; 81: 75–82
- Khoo S.-M., Humberstone A. J., Porter C. J. H., Edwards G. A., Charman C. W. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. International Journal of Pharmaceutics 1998; 167: 155–164
- Lewis G. A., Chariot M. Non classical experimental designs in pharmaceutical formulation. Drug Development and Industrial Pharmacy 1991; 17: 1551–1570
- Moltzen E. K., Perregaard J., Meier E. Sigma ligands with subnanomoal affinity and preference for the σ2 biding site, 2: Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. Journal of Medicinal Chemistry 1995; 38: 2009–2017
- Snee R. D. Design and analysis of mixture experiments. Journal of Quality and Technology 1971; 3: 159–169
- Taha E. I., Samy A. M., Kassem A. A., Khan M. A. Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharmaceutical Development and Technology 2005; 10: 363–370
- Wold S., Johansson E., Cocchi M. PLS – partial least-squares projections to latent structures. 3D QSAR in Drug Design, H. Kubinyi. Informa UK Ltd, Leiden 1993; 523–550